MassIVE MSV000097496

Partial Public PXD062529

Pan-neurodegeneration proteomics reveals disease subtypes and altered molecular signatures in six neurodegenerative disorders

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

Neurodegenerative diseases (NDs) pose clinical challenges due to their complexity and molecular heterogeneity, limiting effective diagnosis and treatment. Here, we present an unprecedented multi-layered proteomic atlas of over 2,000 human brain samples spanning controls and six major NDs, including Alzheimer's disease (AD), Lewy body dementia (LBD), frontotemporal lobar degeneration (FTLD), vascular dementia (VAD), Parkinson's disease (PD), and progressive supranuclear palsy (PSP). The profiling includes the whole proteome, detergent-insoluble aggregation-enriched proteome, and post-translational modifications of phosphorylation and ubiquitination. The atlas reveals distinct intra-disease and inter-disease proteomic signatures. The intra-disease analysis uncovers distinct molecular subtypes and dysregulated pathways within each ND, such as three AD subtypes and four LBD subtypes, independent of known pathological classifications. Inter-disease analysis identifies shared alterations in neuroinflammation and synaptic dysfunction and disease-specific alterations in protein aggregation, response to unfolded proteins and activation of developmental signaling. This large-scale proteomics study provides critical insights into ND mechanisms and offers a unique resource for future research. [doi:10.25345/C5BK1724K] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Neurodegenerative diseases (NDs) ; proteomics ; proteome ; mass spectrometry ; protein aggregation ; Abeta ; amyloid ; tau ; TDP-43 ; alpha-synuclein ; U1 snRNP ; post-translational modifications (PTMs) ; phosphorylation ; ubiquitination ; Lewy body dementia (LBD) ; frontotemporal lobar degeneration (FTLD) ; vascular dementia (VAD) ; progressive supranuclear palsy (PSP) ; molecular subtypes ; disease network ; Parkinson (PD) ; Alzheimer (AD) ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order) 		Junmin Peng, St. Jude Children's Research Hospital, USA
Submitting User: PanNDproject_stjude
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.